The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vaxil Bio Change To Liabilities account and
Change To Operating Activities. At this time, the significance of the direction appears to have no relationship.
The correlation between Vaxil Bio's Change To Liabilities and Change To Operating Activities is 0.04. Overlapping area represents the amount of variation of Change To Liabilities that can explain the historical movement of Change To Operating Activities in the same time period over historical financial statements of Vaxil Bio, assuming nothing else is changed. The correlation between historical values of Vaxil Bio's Change To Liabilities and Change To Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Liabilities of Vaxil Bio are associated (or correlated) with its Change To Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Operating Activities has no effect on the direction of Change To Liabilities i.e., Vaxil Bio's Change To Liabilities and Change To Operating Activities go up and down completely randomly.
Correlation Coefficient | 0.04 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Most indicators from Vaxil Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxil Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to drop to 114.00 in 2024.
Enterprise Value Over EBITDA is likely to climb to -9.3 in 2024
When running Vaxil Bio's price analysis, check to
measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to
predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.